github link
Accession IconGSE57626

NAD+ and PPAR-modifying drugs in a C. elegans model of respiratory chain complex I deficiency

Organism Icon Caenorhabditis elegans
Sample Icon 64 Downloadable Samples
Technology Badge Icon Affymetrix C. elegans Genome Array (celegans)

Submitter Supplied Information

Description
The gas-1(fc21) mutation affects the 49 kD subunit of complex I, decreasing the rate of complex I-dependent oxidative phosphorylation. This is a model for human mitochondrial respiratory chain disease. NAD+ and PPAR-modifying drugs may confer benefits with respect to lifespan in these short-lived mutant worms. Analysis of gas-1(fc21) electron transport chain complex I mutants treated either starting in development or in young adulthood only with nicotinic acid (1 mM), resveratrol (50 microM), rosiglitazone (5 mM) or fenofibrate (14 microM) is presented. The goal is to detect transcriptional changes in clusters of genes using gene set enrichment analysis to explain treament effects in these mutant worms.
PubMed ID
No associated PubMed ID
Publication Title
No associated publication
Total Samples
64
Submitter’s Institution
Authors
No associated authors

Samples

Show of 0 Total Samples
Filter
Add/Remove
Accession Code
Title
Processing Information
Additional Metadata
No rows found
Loading...